Entry note
NVO: Rates and duration desk
Reads yields, dollar pressure, TLT, banks, and rate-sensitive growth. Novo Nordisk is back near $413.30, so the desk marked it as actionable. If price loses $390.57, the idea gets downgraded quickly.
$413.30Entry
$390.57Risk rule
$440.16Focus